Business
Onco-Innovations Announces Closing of Private Placement
Not for distribution to United States wire services or for dissemination in the United States VANCOUVER, BC / ACCESS Newswire / March 12, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") ...
About this update from Onco-innovations Ltd.
[{"type":"text","content":"Not for distribution to United States wire services or for dissemination in the United States","length":93,"tagName":"p"},{"type":"text","content":"VANCOUVER, BC / ACCESS Newswire / March 12, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") is pleased to announce that it has closed its previously-announced (see the announcement news release dated January 23, 2026 and the news release announcing the amendment to non-brokered private placement dated February 12, 2026) non-brokered private placement (the "Private Placement"), issuing1,870,000 units of the Company (the "Units") at a price of $0.65 per Unit for aggregate gross proceeds of $1,215,500. Each Unit is comprised of one common share (each a "Share") and one common share purchase warrant (each whole warrant, a "Warrant"), with each Warrant entitling the holder to purchase one Share at a price of $0.75 for a period of three (3) years, such date being March 12, 2029.","length":909,"tagName":"p"},{"type":"text","content":"The proceeds from the Private Placement will be used for general corporate and working capital purposes, including in pursuit of the Company's operational, research and development, and investor relations objectives.","length":220,"tagName":"p"},{"type":"text","content":"The Company has also issued 18,700 Shares ("AdministrativeShares") of the Company to an arm's-length third party, in consideration for administrative services rendered in connection with the Private Placement.","length":223,"tagName":"p"},{"type":"text","content":"Pursuant to applicable securities laws, all securities issued in connection with the Private Placement will be subject to a statutory hold period of four months and one day.","length":173,"tagName":"p"},{"type":"text","content":"The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or any U.S. state securities laws, and may not be offered or sold in the United States absent registration or available exemptions from such registration requirements. This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities in the United States, or in any jurisdiction in which such offer...